Company: INMB
Filing Date: 2025-02-10
Form Type: 8-K
Source: 0001213900-25-011733
Chunk: 1

Company: Inmune Bio, Inc.
Filing Date: 2025-02-10
Form: 8-K
Item: Item 1.01
Chunk 1
---
 party or upon the bankruptcy or insolvency of the other party.

The
foregoing description of the material terms of the License Agreement does not purport to be complete and is qualified in its entirety
by reference to the complete text of the License Agreement, a copy of which is filed herewith as Exhibit 10.1 to this Current Report
on Form 8-K and is incorporated herein by reference.

Item 1.02 Termination of a Material Definitive
Agreement.

On February 6, 2025, the Company and Silicon Valley
Bank, a division of First-Citizens Bank & Trust Company (“ SVB”) entered into a letter agreement pursuant to which the
Company and SVB terminated the Loan and Security Agreement (the “ Loan Agreement”) dated as of June 10, 2021, by and between
the Company, as borrower, and SVB as administrative agent, collateral agent and lender and SVB Innovation Credit Fund VIII, L. P., as a
lender, pursuant to a termination letter (the “ Termination Letter”).

As of the date of the Termination Letter, no amounts
were due or owed by the Company to SVB under the Loan Agreement. No early termination penalty was paid in connection with the Termination
Letter.

Pursuant to the Termination Letter and in accordance
with the terms of the Loan Agreement, the Company continues to be bound by certain terms under the Loan Agreement that customarily survive
the termination of similar agreements, including, without limitation, certain indemnification obligations.

The foregoing description of the Termination Letter
is qualified in its entirety by reference to such document, which is filed as Exhibit 10.2 to this Current Report on Form 8-K and is
incorporated herein by reference.

Item
8.01. Other Events.

On February 10, 2025, the Company issued a press release announcing
its entry into the License Agreement. A copy of the press release is filed herewith as Exhibit 99.1 to this Current Report on Form 8-K
and is incorporated herein by reference.

Item
9.01 Financial Statements and Exhibits.